Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag  

Event Features

PEGS Europe is the largest European event covering all aspects of protein and antibody engineering. Over the last three years, participation at PEGS Europe has grown by more than 60%, and this year will be the largest ever. With a more-focused technical program, and double the coverage of the most popular PEGS topics, the 2016 event will feature:

  • 700 attendees
  • 200 technical presentations
  • 125 scientific posters
  • Dedicated networking opportunities
  • Exclusive exhibit & poster viewing hours
  • Interactive roundtable, breakout & panel discussions

Colleague Testimonials

“The best biologics technology meeting in Europe: a must-attend conference for novel biologics.”
- Rakesh D., Ph.D., VP, R&D, MedImmune

“PEGS Europe and PEGS keep going from strength to strength. One week at a PEGS event can stimulate ideas for a whole year. The presentations were exceptional, covering an extraordinary array of antibody and antibody-alternative technologies. PEGS Europe is unparalleled in both scope and quality.”
- Kevin R., Ph.D., Scientist, Wellcome Trust Sanger Institute

“Once more, PEGS Europe was an outstanding event with great science and a perfect setting for networking. Very nice combination of topics and speakers.”
- Philipp M., Ph.D., Project Leader, Biomedicine, University Hospital of Basel

“PEGS Europe is a gem for protein engineers with depth and breadth in a stimulating and engaging environment! I am glad that I came all the way from California to be a part of it.”
- Seung C., Ph.D., Associate Director, Cell Biology, Xencor, Inc.

“A great event, packed with so much knowledge and great speakers, offering a unique balance between academic research and industrial applications. In short: offering a compact source of inspiration.”
- Jonas S., Ph.D., Head, High-Throughput Laboratory, Biochemistry, University of Zurich

Read More Testimonials

Premier Sponsors

Albumedix
Twist Bioscience

View All Sponsors

More sponsor & exhibit information



Plenary Keynotes

Paul AdamPaul Adam, Ph.D.,

Boehringer Ingelheim


Christian KleinChristian Klein, Ph.D.,

Roche Pharmaceutical Research and Early Development


Sandra DieboldSandra S. Diebold, Ph.D.,

National Institute for Biological Standards and Control